메뉴 건너뛰기




Volumn 68, Issue 12, 2008, Pages 1723-1739

Mometasone furoate: A review of its intranasal use in allergic rhinitis

Author keywords

Adis Drug Evaluations; Allergic rhinitis; Intranasal; Mometasone, general

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETAMETHASONE; BUDESONIDE; FLUTICASONE PROPIONATE; GAMMA INTERFERON; GLUCOCORTICOID RECEPTOR; HISTAMINE; HYDROCORTISONE; IMMUNOGLOBULIN E; INTERLEUKIN 1; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LEUKOTRIENE; LORATADINE; MOMETASONE FUROATE; NEDOCROMIL; PLACEBO; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA;

EID: 49149123222     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200868120-00009     Document Type: Review
Times cited : (20)

References (55)
  • 1
    • 0031736127 scopus 로고    scopus 로고
    • Mometasone furoate: A review of its intranasal use in allergic rhinitis
    • Oct;
    • Onrust SV, Lamb HM. Mometasone furoate: a review of its intranasal use in allergic rhinitis. Drugs 1998 Oct; 56 (4): 725-45
    • (1998) Drugs , vol.56 , Issue.4 , pp. 725-745
    • Onrust, S.V.1    Lamb, H.M.2
  • 4
    • 0031962431 scopus 로고    scopus 로고
    • Topical mometasone: A review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders
    • Prakash A, Benfield P. Topical mometasone: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders. Drugs 1998; 55 (1): 145-63
    • (1998) Drugs , vol.55 , Issue.1 , pp. 145-163
    • Prakash, A.1    Benfield, P.2
  • 5
    • 33745459272 scopus 로고    scopus 로고
    • Inhaled mometasone furoate: A review of its use in persistent asthma in adults and adolescents
    • McCormack PL, Plosker GL. Inhaled mometasone furoate: a review of its use in persistent asthma in adults and adolescents. Drugs 2006; 66 (8): 1151-68
    • (2006) Drugs , vol.66 , Issue.8 , pp. 1151-1168
    • McCormack, P.L.1    Plosker, G.L.2
  • 6
    • 45149130619 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: Potential effects on clinical safety and efficacy
    • Hochhaus G. Pharmacokinetic/pharmacodynamic profile of mometasone furoate nasal spray: potential effects on clinical safety and efficacy. Clin Ther 2008; 30 (1): 1-13
    • (2008) Clin Ther , vol.30 , Issue.1 , pp. 1-13
    • Hochhaus, G.1
  • 7
    • 7844246562 scopus 로고    scopus 로고
    • Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis
    • Nov;
    • Frieri M, Therattil J, Chavarria V, et al. Effect of mometasone furoate on early and late phase inflammation in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1998 Nov; 81 (5 Pt 1): 431-7
    • (1998) Ann Allergy Asthma Immunol , vol.81 , Issue.5 PART 1 , pp. 431-437
    • Frieri, M.1    Therattil, J.2    Chavarria, V.3
  • 8
    • 49149123772 scopus 로고    scopus 로고
    • Effects of brief corticosteroid treatment on immediate and late phase symptoms, mediator release, and cellular influx in allergic rhinitis [abstract no. 1072]
    • Sanico AM, Feinstein M, Wu XQ, et al. Effects of brief corticosteroid treatment on immediate and late phase symptoms, mediator release, and cellular influx in allergic rhinitis [abstract no. 1072]. J Allergy Clin Immunol 2000; 105 (2): 365
    • (2000) J Allergy Clin Immunol , vol.105 , Issue.2 , pp. 365
    • Sanico, A.M.1    Feinstein, M.2    Wu, X.Q.3
  • 9
    • 0035063093 scopus 로고    scopus 로고
    • Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge
    • Apr;
    • Ciprandi G, Tosca MA, Passalacqua G, et al. Intranasal mometasone furoate reduces late-phase inflammation after allergen challenge. Ann Allergy Asthma Immunol 2001 Apr; 86 (4): 433-8
    • (2001) Ann Allergy Asthma Immunol , vol.86 , Issue.4 , pp. 433-438
    • Ciprandi, G.1    Tosca, M.A.2    Passalacqua, G.3
  • 10
    • 0031921886 scopus 로고    scopus 로고
    • Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis
    • May;
    • Minshall E, Ghaffar O, Cameron L, et al. Assessment by nasal biopsy of long-term use of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol Head Neck Surg 1998 May; 118 (5): 648-54
    • (1998) Otolaryngol Head Neck Surg , vol.118 , Issue.5 , pp. 648-654
    • Minshall, E.1    Ghaffar, O.2    Cameron, L.3
  • 11
    • 0036627699 scopus 로고    scopus 로고
    • A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis
    • Jun;
    • Bende M, Carrillo T, Vona I, et al. A randomized comparison of the effects of budesonide and mometasone furoate aqueous nasal sprays on nasal peak flow rate and symptoms in perennial allergic rhinitis. Ann Allergy Asthma Immunol 2002 Jun; 88 (6): 617-23
    • (2002) Ann Allergy Asthma Immunol , vol.88 , Issue.6 , pp. 617-623
    • Bende, M.1    Carrillo, T.2    Vona, I.3
  • 12
    • 0032997178 scopus 로고    scopus 로고
    • Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis
    • Jan;
    • Berkowitz RB, Bernstein DI, LaForce C, et al. Onset of action of mometasone furoate nasal spray (NASONEX) in seasonal allergic rhinitis. Allergy 1999 Jan; 54 (1): 64-9
    • (1999) Allergy , vol.54 , Issue.1 , pp. 64-69
    • Berkowitz, R.B.1    Bernstein, D.I.2    LaForce, C.3
  • 13
    • 0033124517 scopus 로고    scopus 로고
    • Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting
    • Berkowitz RB, Roberson S, Zora J, et al. Mometasone furoate nasal spray is rapidly effective in the treatment of seasonal allergic rhinitis in an outdoor (park), acute exposure setting. Allergy Asthma Proc 1999; 20 (3): 167-72
    • (1999) Allergy Asthma Proc , vol.20 , Issue.3 , pp. 167-172
    • Berkowitz, R.B.1    Roberson, S.2    Zora, J.3
  • 14
    • 49149118080 scopus 로고    scopus 로고
    • Mometasone furoate nasal spray rapidly and enduringly relieves nasal congestion and other symptoms of seasonal allergic rhinitis [abstract no. 251]
    • Gross GN, Danzig MR, Gates D. Mometasone furoate nasal spray rapidly and enduringly relieves nasal congestion and other symptoms of seasonal allergic rhinitis [abstract no. 251]. J Allergy Clin Immunol 2007; 119 (Suppl. 1): 64
    • (2007) J Allergy Clin Immunol , vol.119 , Issue.SUPPL. 1 , pp. 64
    • Gross, G.N.1    Danzig, M.R.2    Gates, D.3
  • 15
    • 0037349178 scopus 로고    scopus 로고
    • Systemic bioactivity of intranasal triamcinolone and mometasone in perennial allergic rhinitis
    • Mar;
    • Lee DK, Robb FM, Sims EJ, et al. Systemic bioactivity of intranasal triamcinolone and mometasone in perennial allergic rhinitis. Br J Clin Pharmacol 2003 Mar; 55 (3): 310-3
    • (2003) Br J Clin Pharmacol , vol.55 , Issue.3 , pp. 310-313
    • Lee, D.K.1    Robb, F.M.2    Sims, E.J.3
  • 16
    • 33750963673 scopus 로고    scopus 로고
    • Safety of mometasone furoate nasal spray in children with allergic rhinitis as young as 2 years of age: A randomized controlled trial
    • Cutler DL, Banfield C, Affrime MB. Safety of mometasone furoate nasal spray in children with allergic rhinitis as young as 2 years of age: a randomized controlled trial. Pediatric Asthma Allergy Immunol 2006; 19 (3): 146-53.
    • (2006) Pediatric Asthma Allergy Immunol , vol.19 , Issue.3 , pp. 146-153
    • Cutler, D.L.1    Banfield, C.2    Affrime, M.B.3
  • 17
    • 0031418173 scopus 로고    scopus 로고
    • Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children
    • Brannan MD, Herron JM, Affrime MB. Safety and tolerability of once-daily mometasone furoate aqueous nasal spray in children. Clin Ther 1997; 19 (6): 1330-9
    • (1997) Clin Ther , vol.19 , Issue.6 , pp. 1330-1339
    • Brannan, M.D.1    Herron, J.M.2    Affrime, M.B.3
  • 18
    • 0032711090 scopus 로고    scopus 로고
    • Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide
    • Nov;
    • Agertoft L, Pedersen S. Short-term lower leg growth rate in children with rhinitis treated with intranasal mometasone furoate and budesonide. J Allergy Clin Immunol 1999 Nov; 104 (5): 948-52
    • (1999) J Allergy Clin Immunol , vol.104 , Issue.5 , pp. 948-952
    • Agertoft, L.1    Pedersen, S.2
  • 19
    • 0034132570 scopus 로고    scopus 로고
    • Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray
    • Feb;
    • Schenkel EJ, Skoner DP, Bronsky EA, et al. Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000 Feb; 105 (2): E22
    • (2000) Pediatrics , vol.105 , Issue.2
    • Schenkel, E.J.1    Skoner, D.P.2    Bronsky, E.A.3
  • 20
    • 3142722670 scopus 로고    scopus 로고
    • Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays
    • Jun;
    • Daley-Yates PT, Kunka RL, Yin Y, et al. Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays. Eur J Clin Pharmacol 2004 Jun; 60 (4): 265-8
    • (2004) Eur J Clin Pharmacol , vol.60 , Issue.4 , pp. 265-268
    • Daley-Yates, P.T.1    Kunka, R.L.2    Yin, Y.3
  • 21
    • 35248838260 scopus 로고    scopus 로고
    • Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate
    • Tayab ZR, Fardon TC, Lee DKC, et al. Pharmacokinetic/pharmacodynamic evaluation of urinary cortisol suppression after inhalation of fluticasone propionate and mometasone furoate. Br J Clin Pharmacol 2007; 64 (5): 698-705.
    • (2007) Br J Clin Pharmacol , vol.64 , Issue.5 , pp. 698-705
    • Tayab, Z.R.1    Fardon, T.C.2    Lee, D.K.C.3
  • 22
    • 0036204599 scopus 로고    scopus 로고
    • Bioavailability and metabolism of mometasone furoate: Pharmacology versus methodology
    • Derendorf H, Daley-Yates PT, Pierre LN, et al. Bioavailability and metabolism of mometasone furoate: pharmacology versus methodology. J Clin Pharmacol 2002; 42: 383-7
    • (2002) J Clin Pharmacol , vol.42 , pp. 383-387
    • Derendorf, H.1    Daley-Yates, P.T.2    Pierre, L.N.3
  • 23
    • 0029793604 scopus 로고    scopus 로고
    • Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: An active- and placebo-controlled study
    • Aug;
    • Hebert JR, Nolop K, Lutsky BN. Once-daily mometasone furoate aqueous nasal spray (Nasonex) in seasonal allergic rhinitis: an active- and placebo-controlled study. Allergy 1996 Aug; 51 (8): 569-76
    • (1996) Allergy , vol.51 , Issue.8 , pp. 569-576
    • Hebert, J.R.1    Nolop, K.2    Lutsky, B.N.3
  • 24
    • 0030789152 scopus 로고    scopus 로고
    • Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis
    • Jul;
    • Bronsky EA, Aaronson DW, Berkowitz RB, et al. Dose ranging study of mometasone furoate (Nasonex) in seasonal allergic rhinitis. Ann Allergy Asthma Immunol 1997 Jul; 79 (1): 51-6
    • (1997) Ann Allergy Asthma Immunol , vol.79 , Issue.1 , pp. 51-56
    • Bronsky, E.A.1    Aaronson, D.W.2    Berkowitz, R.B.3
  • 25
    • 0032872992 scopus 로고    scopus 로고
    • A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis
    • Jul;
    • Meltzer EO, Berger WE, Berkowitz RB, et al. A dose-ranging study of mometasone furoate aqueous nasal spray in children with seasonal allergic rhinitis. J Allergy Clin Immunol 1999 Jul; 104 (1): 107-14
    • (1999) J Allergy Clin Immunol , vol.104 , Issue.1 , pp. 107-114
    • Meltzer, E.O.1    Berger, W.E.2    Berkowitz, R.B.3
  • 26
    • 49149129122 scopus 로고    scopus 로고
    • Mometasone furoate nasal spray is safe and effective for one-year treatment of children with perennial allergic rhinitis
    • Feb;
    • Teper A, Ratner PH. Mometasone furoate nasal spray is safe and effective for one-year treatment of children with perennial allergic rhinitis. J Allergy Clin Immunol 2008 Feb; 121 (Suppl. 2A): 52-3.
    • (2008) J Allergy Clin Immunol , vol.121 , Issue.SUPPL. 2A , pp. 52-53
    • Teper, A.1    Ratner, P.H.2
  • 27
    • 49149109232 scopus 로고    scopus 로고
    • Efficacy and long-term safety of mometasone furoate nasal spray in children 3-11 years with perennial allergic rhinitis [abstract no. 249]
    • Patel P. Efficacy and long-term safety of mometasone furoate nasal spray in children 3-11 years with perennial allergic rhinitis [abstract no. 249]. Ann Allergy Asthma Immunol 2008; 100 (Suppl. 1): A90
    • (2008) Ann Allergy Asthma Immunol , vol.100 , Issue.SUPPL. 1
    • Patel, P.1
  • 28
    • 40849086359 scopus 로고    scopus 로고
    • Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis
    • for the Mometasone Furoate Nasal Spray With Loratadine Study Group
    • Anolik R, for the Mometasone Furoate Nasal Spray With Loratadine Study Group. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2008; 100 (3): 264-71
    • (2008) Ann Allergy Asthma Immunol , vol.100 , Issue.3 , pp. 264-271
    • Anolik, R.1
  • 29
    • 0345373505 scopus 로고    scopus 로고
    • Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients
    • Aug;
    • Drouin M, Yang WH, Bertrand B, et al. Once daily mometasone furoate aqueous nasal spray is as effective as twice daily beclomethasone dipropionate for treating perennial allergic rhinitis patients. Ann Allergy Asthma Immunol 1996 Aug; 77 (2): 153-60
    • (1996) Ann Allergy Asthma Immunol , vol.77 , Issue.2 , pp. 153-160
    • Drouin, M.1    Yang, W.H.2    Bertrand, B.3
  • 30
    • 14444279678 scopus 로고    scopus 로고
    • Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group
    • Oct;
    • Mandl M, Nolop K, Lutsky BN. Comparison of once daily mometasone furoate (Nasonex) and fluticasone propionate aqueous nasal sprays for the treatment of perennial rhinitis. 194-079 Study Group. Ann Allergy Asthma Immunol 1997 Oct; 79 (4): 370-8
    • (1997) Ann Allergy Asthma Immunol , vol.79 , Issue.4 , pp. 370-378
    • Mandl, M.1    Nolop, K.2    Lutsky, B.N.3
  • 31
    • 0029958150 scopus 로고    scopus 로고
    • A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray
    • Oct;
    • Graft D, Aaronson D, Chervinsky P, et al. A placebo- and active-controlled randomized trial of prophylactic treatment of seasonal allergic rhinitis with mometasone furoate aqueous nasal spray. J Allergy Clin Immunol 1996 Oct; 98 (4): 724-31
    • (1996) J Allergy Clin Immunol , vol.98 , Issue.4 , pp. 724-731
    • Graft, D.1    Aaronson, D.2    Chervinsky, P.3
  • 32
    • 33646728948 scopus 로고    scopus 로고
    • Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis
    • May;
    • Pitsios C, Papadopoulos D, Kompoti E, et al. Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol 2006 May; 96 (5): 673-8
    • (2006) Ann Allergy Asthma Immunol , vol.96 , Issue.5 , pp. 673-678
    • Pitsios, C.1    Papadopoulos, D.2    Kompoti, E.3
  • 33
    • 49149084614 scopus 로고    scopus 로고
    • Efficacy and safety of desloratadine and mometasone furoate combination therapy for seasonal allergic rhinitis and related sleep disturbances [abstract no. P222]
    • Grevers G, Karmann B. Efficacy and safety of desloratadine and mometasone furoate combination therapy for seasonal allergic rhinitis and related sleep disturbances [abstract no. P222]. Ann Allergy Asthma Immunol 2007; 98 (Suppl. 1): A92
    • (2007) Ann Allergy Asthma Immunol , vol.98 , Issue.SUPPL. 1
    • Grevers, G.1    Karmann, B.2
  • 34
    • 39149123283 scopus 로고    scopus 로고
    • Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate
    • Mar;
    • Bielory L. Ocular symptom reduction in patients with seasonal allergic rhinitis treated with the intranasal corticosteroid mometasone furoate. Ann Allergy Asthma Immunol 2008 Mar; 100 (3): 272-9
    • (2008) Ann Allergy Asthma Immunol , vol.100 , Issue.3 , pp. 272-279
    • Bielory, L.1
  • 35
    • 49149100163 scopus 로고    scopus 로고
    • Improvement in nasal and ocular symptom scores seen with desloratadine in combination with mometasone furoate in patients with moderate-to-severe seasonal allergic rhinitis [abstract no. P218]
    • Jan;
    • Grevers G, Karmann B. Improvement in nasal and ocular symptom scores seen with desloratadine in combination with mometasone furoate in patients with moderate-to-severe seasonal allergic rhinitis [abstract no. P218]. Ann Allergy Asthma Immunol 2007 Jan; 98 (Suppl. 1): A91
    • (2007) Ann Allergy Asthma Immunol , vol.98 , Issue.SUPPL. 1
    • Grevers, G.1    Karmann, B.2
  • 36
    • 24344451143 scopus 로고    scopus 로고
    • A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis
    • Meltzer EO, Bardelas J, Goldsobel A, et al. A preference evaluation study comparing the sensory attributes of mometasone furoate and fluticasone propionate nasal sprays by patients with allergic rhinitis. Treat Respir Med 2005; 4 (4): 289-96
    • (2005) Treat Respir Med , vol.4 , Issue.4 , pp. 289-296
    • Meltzer, E.O.1    Bardelas, J.2    Goldsobel, A.3
  • 37
    • 2342618740 scopus 로고    scopus 로고
    • Cost efficiency of intranasal corticosteroid prescribing patterns in the management of allergic rhinitis
    • Jan;
    • Reissman D, Price T, Leibman CW. Cost efficiency of intranasal corticosteroid prescribing patterns in the management of allergic rhinitis. J Manag Care Pharm 2004 Jan; 10 (1): S9-13
    • (2004) J Manag Care Pharm , vol.10 , Issue.1
    • Reissman, D.1    Price, T.2    Leibman, C.W.3
  • 38
    • 0033508816 scopus 로고    scopus 로고
    • A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis
    • Lumry WR. A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis. J Allergy Clin Immunol 1999; 104 (4 Pt 1): S150-8
    • (1999) J Allergy Clin Immunol , vol.104 , Issue.4 PART 1
    • Lumry, W.R.1
  • 39
    • 49149101439 scopus 로고    scopus 로고
    • Long-term ocular safety of mometasone furoate nasal spray during treatment of perennial allergic rhinitis [abstract no. 194]
    • Bernstein D. Long-term ocular safety of mometasone furoate nasal spray during treatment of perennial allergic rhinitis [abstract no. 194]. Allergy 2008; 63 (Suppl. 88): 87
    • (2008) Allergy , vol.63 , Issue.SUPPL. 88 , pp. 87
    • Bernstein, D.1
  • 40
    • 6044220195 scopus 로고    scopus 로고
    • Allergic rhinitis in children: Diagnosis and management strategies
    • Berger WE. Allergic rhinitis in children: diagnosis and management strategies. Pediatr Drugs 2004; 6 (4): 233-50
    • (2004) Pediatr Drugs , vol.6 , Issue.4 , pp. 233-250
    • Berger, W.E.1
  • 41
    • 35248850220 scopus 로고    scopus 로고
    • A survey of the burden of allergic rhinitis in Europe
    • Canonica GW, Bousquet J, Mullol J, et al. A survey of the burden of allergic rhinitis in Europe. Allergy 2007; 62 (Suppl. 85): 17-25
    • (2007) Allergy , vol.62 , Issue.SUPPL. 85 , pp. 17-25
    • Canonica, G.W.1    Bousquet, J.2    Mullol, J.3
  • 42
    • 0036844045 scopus 로고    scopus 로고
    • Intranasal corticosteroids for allergic rhinitis
    • Trangsrud AJ, Whitaker AL, Small RE. Intranasal corticosteroids for allergic rhinitis. Pharmacotherapy 2002; 22 (11): 1458-67
    • (2002) Pharmacotherapy , vol.22 , Issue.11 , pp. 1458-1467
    • Trangsrud, A.J.1    Whitaker, A.L.2    Small, R.E.3
  • 43
    • 33846930674 scopus 로고    scopus 로고
    • Herman H. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost. Am J Rhinol 2007 Jan 2007 28; 21 (1): 70-9
    • Herman H. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost. Am J Rhinol 2007 Jan 2007 28; 21 (1): 70-9
  • 44
    • 49149131754 scopus 로고    scopus 로고
    • Evidence-based approaches to the management of allergic rhinitis: An educational initiative for managed markets [online]. Available from URL
    • Accessed 2008 Apr 1
    • First Report®. Evidence-based approaches to the management of allergic rhinitis: an educational initiative for managed markets [online]. Available from URL: http://www.princetoncme.com/pdf/programs/report586.pdf [Accessed 2008 Apr 1]
    • First Report®
  • 46
    • 35048902383 scopus 로고    scopus 로고
    • Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA2LEN
    • Cruz AA, Popov T, Pawankar R, et al. Common characteristics of upper and lower airways in rhinitis and asthma: ARIA update, in collaboration with GA2LEN. Allergy 2007; 62 (Suppl. 84): 1-41
    • (2007) Allergy , vol.62 , Issue.SUPPL. 84 , pp. 1-41
    • Cruz, A.A.1    Popov, T.2    Pawankar, R.3
  • 47
    • 31544480665 scopus 로고    scopus 로고
    • International Primary Care Respiratory Group (IPCRG) guidelines: Management of allergic rhinitis
    • Feb;
    • Price D, Bond C, Bouchard J, et al. International Primary Care Respiratory Group (IPCRG) guidelines: management of allergic rhinitis. Prim Care Respir J 2006 Feb; 15 (1): 58-70
    • (2006) Prim Care Respir J , vol.15 , Issue.1 , pp. 58-70
    • Price, D.1    Bond, C.2    Bouchard, J.3
  • 48
    • 36849060518 scopus 로고    scopus 로고
    • BSACI guidelines for the management of allergic and non-allergic rhinitis
    • Jan;
    • Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clin Exp Allergy 2008 Jan; 38 (1): 19-42
    • (2008) Clin Exp Allergy , vol.38 , Issue.1 , pp. 19-42
    • Scadding, G.K.1    Durham, S.R.2    Mirakian, R.3
  • 50
    • 49149109777 scopus 로고    scopus 로고
    • online, Available from URL:, Accessed 2008 Apr 18
    • Patient UK. Allergic rhinitis: leaflet print [online]. Available from URL: http://www.patient.co.uk/showdoc/40025266/#related_l [Accessed 2008 Apr 18]
    • Allergic rhinitis: Leaflet print
    • Patient, U.K.1
  • 51
    • 0033949705 scopus 로고    scopus 로고
    • Safety of inhaled and intranasal corticosteroids: Lessons for the new millennium
    • Jul;
    • Lipworth BJ, Jackson CM. Safety of inhaled and intranasal corticosteroids: lessons for the new millennium. Drug Saf 2000 Jul; 23 (1): 11-33
    • (2000) Drug Saf , vol.23 , Issue.1 , pp. 11-33
    • Lipworth, B.J.1    Jackson, C.M.2
  • 52
    • 0345415766 scopus 로고    scopus 로고
    • Intranasal steroid sprays in the treatment of rhinitis: Is one better than another?
    • Nov;
    • Waddell AN, Patel SK, Toma AG, et al. Intranasal steroid sprays in the treatment of rhinitis: is one better than another? J Laryngol Otol 2003 Nov; 117 (11): 843-5
    • (2003) J Laryngol Otol , vol.117 , Issue.11 , pp. 843-845
    • Waddell, A.N.1    Patel, S.K.2    Toma, A.G.3
  • 53
    • 32544435780 scopus 로고    scopus 로고
    • Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: Are they all the same?
    • Yawn B. Comparison of once-daily intranasal corticosteroids for the treatment of allergic rhinitis: are they all the same? MedGenMed 2006; 8 (1): 23
    • (2006) MedGenMed , vol.8 , Issue.1 , pp. 23
    • Yawn, B.1
  • 54
    • 44049095231 scopus 로고    scopus 로고
    • US prescribing information [online, Available from URL:, Accessed 2008 Jul 25
    • GlaxoSmithKline. VeramystRM (fluticasone furoate) nasal spray: US prescribing information [online]. Available from URL: http://us.gsk.com/ products/assets/us_veramyst.pdf [Accessed 2008 Jul 25]
    • VeramystRM (fluticasone furoate) nasal spray
    • GlaxoSmithKline1
  • 55
    • 49149129008 scopus 로고    scopus 로고
    • online, Available from URL:, Accessed 2008 Jul 4
    • Arthritis Foundation. Delivery systems: nasonexRM (mometasone furoate monohydrate) [online]. Available from URL: http://www.arthritis.org/ease-of-use- new.php?p_id=41 [Accessed 2008 Jul 4]
    • Delivery systems: NasonexRM (mometasone furoate monohydrate)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.